Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

208.84 -6.14 (-2.86%)
Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
News headline image
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
By Financial Research Feature April 3, 2026 Introduction In the high-stakes arena of global biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has long stood as a paragon of scientific... 
Via Finterra
Topics Economy Intellectual Property World Trade
News headline image
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory ↗
Dividend payers might become more popular if the recent volatility continues. These two stocks are great picks to weather the storm. 
Via The Motley Fool
Topics Economy Retirement Stocks
News headline image
Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
BRUSSELS — In a major victory for one of the world’s leading pharmaceutical giants, the European Commission (EC) has officially granted marketing authorization for Merck & Co. (NYSE: MRK) blockbuster... 
Via MarketMinute
Topics Intellectual Property
News headline image
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa... 
Via StockStory
Topics Government Stocks World Trade
News headline image
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
As we enter the second quarter of 2026, Johnson & Johnson (NYSE: JNJ) stands as a starkly different entity than the consumer-facing conglomerate that defined the 20th century. Having successfully shed... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
In a move that signals a decisive shift in the treatment of chronic autoimmune conditions, Gilead Sciences (NASDAQ:GILD) announced on March 23, 2026, its definitive agreement to acquire Ouro Medicines... 
Via MarketMinute
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
In a month characterized by macroeconomic headwinds and a broader cooling of the biotechnology sector, Corcept Therapeutics (NASDAQ: CORT) has emerged as a definitive outlier. While the S&P Biotech ETF... 
Via MarketMinute
Topics ETFs Intellectual Property Stocks
News headline image
Merck Just Made a Big Bet on a New Cancer Growth Engine ↗
Via MarketBeat
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
The Schwab U.S. Dividend Equity ETF is increasing its allocation to healthcare dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
Eli Lilly is much more than just a weight loss stock. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
INDIANAPOLIS – In a move that has left some retail investors scratching their heads, shares of Eli Lilly and Company (NYSE:LLY) have trended lower this week, despite the pharmaceutical giant releasing... 
Via MarketMinute
News headline image
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends ↗
The stock has averaged annual gains of 16.2% over the past decade, and it sports a generous dividend yield, too. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more... 
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
The Fed Is Worried About Trump-Fueled Inflation. Are Your Stocks Safe? ↗
Investors should be prepared in case inflation remains higher than expected. 
Via The Motley Fool
Topics Economy Government World Trade
News headline image
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill. ↗
This pair busts the myth of the sector being a desert for income investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
Shares of pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) climbed 3.3% in early trading on Monday, March 23, 2026, after the company issued a surprisingly robust financial outlook for the fiscal... 
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now ↗
AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation. 
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
In a landmark decision for the dermatology sector, the U.S. Food and Drug Administration (FDA) has officially approved ICOTYDE™ (icotrokinra), a first-of-its-kind oral peptide for the treatment of... 
Via MarketMinute
News headline image
Best Healthcare Stocks to Buy After the Market Pullback ↗
They have the means to recover from recent setbacks. 
Via The Motley Fool
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
These great dividend stocks are especially attractive in the current market conditions. 
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
The pharmaceutical giant AbbVie (NYSE: ABBV) experienced a sharp decline on Wednesday, March 18, 2026, as its stock price tumbled to its lowest level since mid-2025. Shares of the Illinois-based... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
What's Going On With AbbVie Stock Today? ↗
Shares of AbbVie Inc. (NASDAQ: ABBV) are moving lower Wednesday. The stock appears to be trending down after a competitor announced significant progress made on a treatment for plaque psoriasis. 
Via Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
My Top 3 Dividend Kings to Buy for March 2026 ↗
Only the best dividend stocks can achieve "king" status. 
Via The Motley Fool
News headline image
My 5 Favorite Dividend Stocks to Buy Right Now ↗
There are lots of choices, but these are at the top of my list. 
Via The Motley Fool
Topics Retirement
News headline image
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities ↗
Howard Hughes owns large land holdings in fast-growing markets such as Las Vegas, Houston, and Phoenix, where it has developed master-planned communities over many years. Investors will watch whether... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
They are relatively safe wealth compounders. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm ↗
These companies are highly unlikely to go under, no matter what happens. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.